Article
Homocysteine status and polymorphisms of methylenetetrahydrofolate reductase are not associated with restenosis after stenting in coronary arteries.
Arteriosclerosis, thrombosis, and vascular biology - 1 Dec 2003
Koch Werner, Ndrepepa Gjin, Mehilli Julinda, Braun Siegmund, Burghartz Marc, Lengnick Harald, Kölling Klaus, Schömig Albert, Kastrati Adnan
Abstract excerpt
OBJECTIVE: We investigated the influence of elevated homocysteine plasma levels and 2 polymorphisms, 677C/T and 1298A/C, of the methylenetetrahydrofolate reductase (MTHFR) gene on the risk of restenosis after stenting in patients with symptomatic coronary artery disease. METHODS AND RESULTS: Homocysteine levels and MTHFR genotypes were determined in 800 consecutive patients treated with coronary artery stenting....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
